标题
The Two-Faced Cytokine IL-6 in Host Defense and Diseases
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 11, Pages 3528
出版商
MDPI AG
发表日期
2018-11-09
DOI
10.3390/ijms19113528
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Distinct Effects of IL-6 Classic and Trans -Signaling in Bone Fracture Healing
- (2018) Katja Prystaz et al. AMERICAN JOURNAL OF PATHOLOGY
- Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study
- (2018) Guillaume Moulis et al. ANNALS OF THE RHEUMATIC DISEASES
- Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder
- (2018) Gwenaël G.R. Leday et al. BIOLOGICAL PSYCHIATRY
- Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
- (2018) Alex Ganetsky et al. BONE MARROW TRANSPLANTATION
- A potential therapeutic target RNA-binding protein, Arid5a for the treatment of inflammatory disease associated with aberrant cytokine expression
- (2018) Kazuya Masuda et al. CURRENT PHARMACEUTICAL DESIGN
- Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies
- (2018) Sidrah Naseem et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
- (2018) Hoshimi Kawaguchi et al. INTERNAL MEDICINE
- Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients
- (2018) Arsene Mekinian et al. JOURNAL OF AUTOIMMUNITY
- Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis
- (2018) Yubo Ma et al. Modern Rheumatology
- Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy
- (2018) Yoshihito Shima et al. Modern Rheumatology
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a
- (2018) Mitsuru Higa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder
- (2018) Ebrahim Haroon et al. PSYCHONEUROENDOCRINOLOGY
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Hepatic thrombopoietin is required for bone marrow hematopoietic stem cell maintenance
- (2018) Matthew Decker et al. SCIENCE
- Blau syndrome with good Reponses to Tocilizumab: A case report and focused literature review
- (2018) Li Lu et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The impact of targeted Rheumatoid Arthritis pharmacological treatment on mental health: A systematic review and network meta-analysis
- (2018) Faith Matcham et al. Arthritis & Rheumatology
- Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
- (2018) Jose V. Perez-Moreiras et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases
- (2018) Rachel L. Randell et al. PEDIATRIC NEUROLOGY
- First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan
- (2018) Yasuaki Okuda et al. INTERNAL MEDICINE
- Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses
- (2018) Larissa Lamertz et al. Science Signaling
- The role and therapeutic targeting of IL-6 in rheumatoid arthritis
- (2017) Masashi Narazaki et al. Expert Review of Clinical Immunology
- Inflammatory illness: Why the next wave of antidepressants may target the immune system
- (2017) Nicole Wetsman NATURE MEDICINE
- Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab
- (2017) Dagur Ingi Jonsson et al. NEUROMUSCULAR DISORDERS
- Trial of Tocilizumab in Giant-Cell Arteritis
- (2017) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
- (2017) Serdal Ugurlu et al. Orphanet Journal of Rare Diseases
- Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan
- (2017) Shunsuke Mori et al. PLoS One
- Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis
- (2017) H Shimizu et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Interleukin (IL-6) Immunotherapy
- (2017) Toshio Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
- (2017) Claes Held et al. Journal of the American Heart Association
- Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients
- (2017) Vanesa Calvo-Río et al. Arthritis & Rheumatology
- Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
- (2017) Wilmar M Wiersinga Lancet Diabetes & Endocrinology
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
- (2017) Ting Li et al. Scientific Reports
- Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
- (2016) A Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Update of EULAR recommendations for the treatment of systemic sclerosis
- (2016) Otylia Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
- (2016) Valérie Devauchelle-Pensec et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- Immunotherapeutic implications of IL-6 blockade for cytokine storm
- (2016) Toshio Tanaka et al. Immunotherapy
- Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version
- (2016) Yasufumi Masaki et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Arid5a regulates naive CD4+T cell fate through selective stabilization of Stat3 mRNA
- (2016) Kazuya Masuda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
- (2016) C. Tappeiner et al. JOURNAL OF RHEUMATOLOGY
- Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial
- (2016) Johannes W J Bijlsma et al. LANCET
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial
- (2016) Ryota Sakai et al. Modern Rheumatology
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
- (2016) Woo-Jin Lee et al. Neurotherapeutics
- The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome
- (2016) Sean M. Murphy et al. RHEUMATOLOGY
- Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
- (2016) Robert J. Moots et al. RHEUMATOLOGY
- Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
- (2016) Tae-Hwe Heo et al. Oncotarget
- Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica
- (2016) Lindsay Lally et al. Arthritis & Rheumatology
- The pathogenic role of angiogenesis in rheumatoid arthritis
- (2015) Hatem A. Elshabrawy et al. ANGIOGENESIS
- IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
- (2015) Jung-Ta Kao et al. BMC GASTROENTEROLOGY
- Interleukin-6 Stimulates Defective Angiogenesis
- (2015) G. Gopinathan et al. CANCER RESEARCH
- Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms
- (2015) Takashi Mino et al. CELL
- Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis
- (2015) Haifeng Hou et al. INFLAMMATION RESEARCH
- Longterm Safety of Tocilizumab: Results from 3 Years of Followup Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan
- (2015) K. Yamamoto et al. JOURNAL OF RHEUMATOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Tocilizumab for severe refractory neuro-Behçet: Three cases IL-6 blockade in neuro-Behçet
- (2015) Olga Addimanda et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Hepcidin and Host Defense against Infectious Diseases
- (2015) Kathryn Michels et al. PLoS Pathogens
- Brief Report: Takayasu Arteritis and Ulcerative Colitis: High Rate of Co-Occurrence and Genetic Overlap
- (2015) Chikashi Terao et al. Arthritis & Rheumatology
- Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study
- (2015) Mark C. Genovese et al. Arthritis & Rheumatology
- Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial
- (2015) Fabrizio De Benedetti et al. Arthritis & Rheumatology
- The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
- (2014) Christoph Garbers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review
- (2014) Rebecca Stael et al. CLINICAL RHEUMATOLOGY
- Anti-inflammatory therapies for cardiovascular disease
- (2014) P. M. Ridker et al. EUROPEAN HEART JOURNAL
- Targeting classical IL-6 signalling or IL-6trans-signalling in depression?
- (2014) Michael Maes et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation
- (2014) Magdalena K. Poplutz et al. IMMUNOBIOLOGY
- IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
- (2014) Matjaz Rokavec et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-6-Dependent Mucosal Protection Prevents Establishment of a Microbial Niche for Attaching/Effacing Lesion-Forming Enteric Bacterial Pathogens
- (2014) S. M. Dann et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
- (2014) Norihiro Nishimoto et al. Modern Rheumatology
- Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab
- (2014) Sumiyuki Nishida et al. Modern Rheumatology
- A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab
- (2014) Toru Hirano et al. Modern Rheumatology
- Successful treatment with tocilizumab of pericarditis associated with rheumatoid arthritis
- (2014) Shuzo Yoshida et al. Modern Rheumatology
- Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab
- (2014) Yoshihito Shima et al. Modern Rheumatology
- Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease
- (2014) Ei Bannai et al. Modern Rheumatology
- Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
- (2014) M. Araki et al. NEUROLOGY
- Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
- (2014) V De Simone et al. ONCOGENE
- A case of overlap syndrome successfully treated with tocilizumab: a hopeful treatment strategy for refractory dermatomyositis?
- (2014) M. Kondo et al. RHEUMATOLOGY
- Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo
- (2014) Helen L. Wright et al. RHEUMATOLOGY
- A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
- (2014) Toshio Tanaka et al. SEMINARS IN IMMUNOLOGY
- IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function
- (2014) Jan P. Böttcher et al. Cell Reports
- Favorable Responses to Tocilizumab in Two Patients With Cancer-Related Cachexia
- (2013) Haruhiko Hirata et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Treatment of Relapsing Polychondritis with Tocilizumab
- (2013) D. WENDLING et al. JOURNAL OF RHEUMATOLOGY
- Refractory Relapsing Polychondritis Treated with Serial Success with Interleukin 6 Receptor Blockade
- (2013) Z. S. WALLACE et al. JOURNAL OF RHEUMATOLOGY
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
- (2013) T. Koike et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Effect of Tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy
- (2013) Takako Miyamae et al. Modern Rheumatology
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 Regulates Mcl-1L Expression through the JAK/PI3K/Akt/CREB Signaling Pathway in Hepatocytes: Implication of an Anti-Apoptotic Role during Liver Regeneration
- (2013) Chia-Hung Chou et al. PLoS One
- Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
- (2013) Kazuya Masuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study
- (2013) Payman Zamani et al. Journal of the American Heart Association
- Successful Treatment of Anti-Caspr2 Syndrome by Interleukin 6 Receptor Blockade Through Tocilizumab
- (2013) Christos Krogias et al. JAMA Neurology
- Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus
- (2012) Yuko Shirota et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
- (2012) Vivian P Bykerk et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
- (2012) Seiji Ohtori et al. EUROPEAN SPINE JOURNAL
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Tocilizumab for treating refractory haemolytic anaemia in a patient with systemic lupus erythematosus
- (2012) F. J. Garcia-Hernandez et al. RHEUMATOLOGY
- Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF- failure in a patient with relapsing polychondritis complicated by aortitis
- (2012) C. B. Narshi et al. RHEUMATOLOGY
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis
- (2011) Camille Cohen et al. ANNALS OF THE RHEUMATIC DISEASES
- Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*
- (2011) Tanja Barkhausen et al. CRITICAL CARE MEDICINE
- IL-6 plays an essential role in neutrophilia under inflammation
- (2011) Misato Hashizume et al. CYTOKINE
- Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding
- (2011) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic effect of tocilizumab on two patients with polymyositis
- (2011) M. Narazaki et al. RHEUMATOLOGY
- Platelets, inflammation and tissue regeneration
- (2011) Alan Nurden THROMBOSIS AND HAEMOSTASIS
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
- (2010) Chi-Wen Lo et al. CANCER RESEARCH
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tocilizumab for the treatment of rheumatoid arthritis
- (2010) Toshio Tanaka et al. Expert Review of Clinical Immunology
- IL-6: from its discovery to clinical applications
- (2010) T. Kishimoto INTERNATIONAL IMMUNOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Graves' Ophthalmopathy
- (2010) Rebecca S. Bahn NEW ENGLAND JOURNAL OF MEDICINE
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment
- (2009) S Nishida et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Successful treatment of reactive arthritis with a humanized antiâinterleukin-6 receptor antibody, tocilizumab
- (2009) Toshio Tanaka et al. ARTHRITIS AND RHEUMATISM
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
- (2009) Vincent Wai-Sun Wong et al. INTERNATIONAL JOURNAL OF CANCER
- Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
- (2009) Kazufumi Matsushita et al. NATURE
- The role of Toll-like receptors in rheumatoid arthritis
- (2009) Qi-Quan Huang et al. Current Rheumatology Reports
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
- (2008) Shean J Aujla et al. NATURE MEDICINE
- IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17
- (2008) M. Hashizume et al. RHEUMATOLOGY
- Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis
- (2008) M. Kawai et al. RHEUMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now